Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

1,3-Bis(1-adamant-yl)imidazolium tetra-chloridoferrate(III).

ABSTRACT: The crystal structure of the title compound, (C(23)H(33)N(2))[FeCl(4)], consists of 1,3-bis-(1-adamant-yl)imidazolium (BAIM) cations and tetra-hedral tetra-chloridoferrate(III) (TCF) anions. The BAIM cation possesses m symmetry, with the central imidazole ring and four C atoms of each terminal adamantyl group located on a mirror plane. The Fe and two Cl atoms of the TCF anion are also located on the mirror plane. The cyclo-hexane rings of the adamantyl groups adopt normal chair conformations.

SUBMITTER: Ikhile MI

PROVIDER: S-EPMC3009177 | biostudies-literature | 2010 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

1,3-Bis(1-adamant-yl)imidazolium tetra-chloridoferrate(III).

Ikhile Monisola I MI Bala Muhammad D MD

Acta crystallographica. Section E, Structure reports online 20101031 Pt 11

The crystal structure of the title compound, (C(23)H(33)N(2))[FeCl(4)], consists of 1,3-bis-(1-adamant-yl)imidazolium (BAIM) cations and tetra-hedral tetra-chloridoferrate(III) (TCF) anions. The BAIM cation possesses m symmetry, with the central imidazole ring and four C atoms of each terminal adamantyl group located on a mirror plane. The Fe and two Cl atoms of the TCF anion are also located on the mirror plane. The cyclo-hexane rings of the adamantyl groups adopt normal chair conformations. ...[more]

PMID: 21588906

Similar Datasets

Di-μ-chlorido-bis-{bis-[3,5-dimethyl-pyrazol-1-yl-κN)methane]iron(II)} bis-[tetra-chloridoferrate(III)].

Project description:In the title complex, [Fe(2)Cl(2)(C(11)H(16)N(4))(4)][FeCl(4)](2), the asymmetric unit is composed of one and a half units of [Fe(bdmpm)(2)Cl](2)(FeCl(4))(2)(bdmpm = bis(bis(3,5-dimethyl-pyrazol-1-yl)methane). The three independent Fe(II) atom have a distorted octa-hedral coordination geometry comprising two bridging chloride anions and four N atoms from two bis-(3,5-dimethyl-pyrazol-1-yl)methane ligands. The Fe(III) atom has a tetra-hedral coordination geometry comprising four chloride anions.

| S-EPMC2959963 | biostudies-literature

1,3-Dimethyl-1H-1,2,3-benzotriazol-3-ium tetra-chloridoferrate(III).

Project description:The asymmetric unit of the title salt, (C8H10N3)[FeCl4], contains one 1,3-dimethyl-1H-1,2,3-benzotriazol-3-ium cation and one tetra-chloridoferrate anion. The Fe(III) atom in the anion is tetra-hedrally coordinated by four Cl atoms. In the crystal, inter-actions are observed between the Cl atoms and the triazolium ring [Cl?centroid distances = 3.587?(3) and 3.866?(3)?Å].

| S-EPMC3588415 | biostudies-literature

Bis(1,3-dibenzyl-imidazolium) μ-oxido-bis-[trichloridoferrate(III)].

Project description:In the title compound (C(17)H(17)N(2))(2)[Fe(2)Cl(6)O], obtained from the solid-state reaction of FeCl(2) and N,N'-dibenzyl-imidazolium chloride, the complex anion has approximate D(3d) symmetry with crystallographically imposed inversion symmetry coincident with the bridging μ-O atom. The stereochemistry about each FeCl(3)O centre is distorted tetra-hedral [Fe-Cl = 2.2176 (5)-2.2427 (5) Å and Fe-O = 1.7545 (2) Å]. The Cl atoms are involved in weak anion-cation C-H⋯Cl inter-actions, giving a network structure.

| S-EPMC3006938 | biostudies-literature

Bis[1,3-bis-(diphenyl-phosphan-yl)propane]-copper(I) tetra-chlorido-gallate(III).

Project description:In the title compound, [Cu(C??H??P?)?][GaCl?], the Cu(I) atom in the complex cation is P,P'-chelated by two 1,3-bis-(diphenyl-phosphan-yl)propane ligands in a distorted tetra-hedral geometry, while the Ga(III) cation is coordinated by four chloride anions in a distorted tetra-hedral geometry. In the crystal, weak C-H?? inter-actions occur between adjacent complex cations.

| S-EPMC3393151 | biostudies-literature

1,3-Bis(2-cyano-benz-yl)imidazolium bromide.

Project description:In the title salt, C(19)H(15)N(4) (+)·Br(-), the central imidazole ring makes dihedral angles of 83.1 (2) and 87.6 (2)° with the terminal benzene rings. The dihedral angle between the terminal benzene rings is 6.77 (19)°; the cyanide substituents have an anti orientation. In the crystal, the cations and anions are linked via C-H⋯N and C-H⋯Br hydrogen bonds, forming sheets lying parallel to the ac plane.

| S-EPMC3239090 | biostudies-literature

7-(1,3-Dioxolan-2-ylmethyl)-1,3-di-methyl-2,6-dioxo-2,3,6,7-tetra-hydro-1H-purin-9-ium tetra-chloridoferrate(III).

Project description:The asymmetric unit of the title compound, (C(11)H(15)N(4)O(4))[FeCl(4)], contains two independent protonated 7-(1,3-dioxolan-2-ylmeth-yl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (doxofyllinium) and two tetrahedral tetra-chlorido-ferrate(III) anions. In the doxofyllinium, two disordered methyl-ene C atoms are observed in each dioxolane ring with an occupancy ratio of 0.54?(4):0.46?(4). In the crystal, mol-ecules are connected by N-H?O hydrogen bonds and weak C-H?O and C-H?Cl inter-actions.

| S-EPMC2983145 | biostudies-literature

1,3-Bis[(6-methyl-2-pyrid-yl)meth-yl]imidazolium bromide.

Project description:The title compound, C(17)H(19)N(4) (+)·Br(-), is built up from 1,3-bis-[(6-methyl-2-pyridin-yl)meth-yl]imidazolium cations and bromide anions. Each of two 6-methyl-2-pyridyl rings is rotated out of the imidazole plane, making dihedral angles of 79.90?(9) and 86.40?(9)°. The packing is consolidated by aromatic ?-? inter-actions between the pyridine rings of neighbouring mol-ecules [centroid-centroid distance = 3.554?(2)?Å] and by weak C-H?N and C-H?Br hydrogen bonds.

| S-EPMC2968481 | biostudies-literature

{?-5-[1,3-Bis(2,4,6-trimethyl-phen-yl)-3H-imidazolium-2-yl]-2-(2-oxoethenyl-1?C)furan-3-yl-2?C}-?-hydrido-bis(tetra-carbonyl-rhenium) tetra-hydro-furan 0.67-solvate.

Project description:The title complex, [Re(2)(C(27)H(25)N(2)O(2))H(CO)(8)]·0.67C(4)H(8)O, was formed as a product in the reaction of a rhenium(I)-Fischer carbene complex with a free NHC carbene. The coordination environment about the two Re atoms is slightly distorted octahedral, including a bridging H atom. The imidazolium and furan groups are almost coplanar, whereas the mesityl substituents show an almost perpendicular arrangement with respect to both heterocyclic units. Mol-ecules of the complex pack in such a way as to form channels parallel with the bc unit-cell face diagonal running through the unit face diagonal. These channels are partially occupied by tetra-hydro-furan solvent mol-ecules.

| S-EPMC3297260 | biostudies-literature

1,3-Bis(carboxy-meth-yl)imidazolium triiodide 1-carboxyl-atomethyl-3-carboxy-methyl-imidazolium.

Project description:In the title compound, C(7)H(9)N(2)O(4) (+)·I(3) (-)·C(7)H(8)N(2)O(4), the two imidazolium units are hydrogen bonded through the carboxyl groups. The units are further linked via inter-molecular O-H?O hydrogen bonding, resulting in a one-dimensional ladder-type structure. As a result, the two carb-oxy groups of each imidazolium unit adopt a cis configuration with respect to the imidazolium ring.

| S-EPMC2977287 | biostudies-literature

Oxymatrinium tetra-chloridoferrate(III).

Project description:The asymmetric unit of the title compound, (C(15)H(25)N(2)O(2))[FeCl(4)], contains a tetra-chloridoferrate(III) anion and a oxymatrinium cation [oxymatrine is (4R,7aS,13aR,13bR,13cS)-dodeca-hydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one 4-oxide]. The conformation of oxymatrine is similar to that of matrine with one ring having a half-chair conformation, while the others have chair conformations. Chiral chains of cations along the c axis are formed by O-H?O hydrogen bonds.

| S-EPMC3274873 | biostudies-other

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data